Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2012
05/16/2012CN102459180A Urea derivatives as kinase inhibitors
05/16/2012CN102459172A 四环化合物 Tetracyclic compounds
05/16/2012CN102458581A N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
05/16/2012CN102458580A 作为mek抑制剂的杂环化合物 As a heterocyclic compound mek inhibitor
05/16/2012CN102458477A Anti-mesothelin immunoconjugates and uses therefor
05/16/2012CN102458470A Alpha thymosin peptides as vaccine enhancers
05/16/2012CN102458458A Combination immunotherapy compositions against cancer and methods
05/16/2012CN102458428A Nfat signal inhibitor and calcineurin inhibitor
05/16/2012CN102458416A Interlaced method for treating cancer or a precancerous condition
05/16/2012CN102458411A 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
05/16/2012CN102458410A Methods of treatment for solid tumors
05/16/2012CN102458398A Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
05/16/2012CN102458395A Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
05/16/2012CN102458394A Treatment or prophylaxis of proliferative conditions
05/16/2012CN102458392A Antitumor combination including cabazitaxel and capecitabine
05/16/2012CN102458390A Combination of leucine source and omega-3 unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia
05/16/2012CN102458369A Compositions and methods for drug delivery
05/16/2012CN102453715A Small molecular interfering RNA for glioma angiogenesis resistance with high efficiency, preparation method and application thereof
05/16/2012CN102453714A Small interference RNA used for inhibiting glioma migration
05/16/2012CN102453713A HULC siRNA and use of HULC siRNA in preparation of drugs for treatment of liver cancer
05/16/2012CN102453701A Gene modified CDR3 delta transplanted gamma delta T lymphocyte and its antitumor purpose
05/16/2012CN102453097A Angiogenesis inhibiting fusion protein VF and pharmaceutical composition and application thereof
05/16/2012CN102453089A Preparation and application of recombinant consensus interferon mutant polyethylene glycol conjugate
05/16/2012CN102453079A Peptide specifically binding basic fibroblast growth factor receptor
05/16/2012CN102453021A Novel crystal form of lenalidomide and preparation method thereof
05/16/2012CN102453020A Novel crystal form of lenalidomide and preparation method thereof
05/16/2012CN102452990A Homopiperazine acethydrazide derivative with low neurotoxicity and preparation method and application thereof
05/16/2012CN102452989A Aniline substituted quinazoline derivative
05/16/2012CN102452988A Quinazoline derivative and preparation method thereof
05/16/2012CN102452981A 1,3-disubstituted-3-azabicyclo [3,2,1] octane derivatives and preparation method thereof
05/16/2012CN102451474A Antitumor effect, implementation method and usage of miRNA (micro-ribonucleic acid)
05/16/2012CN102451473A MiRNA anti-tumor function, implementation method and application thereof
05/16/2012CN102451433A Preparation method of traditional Chinese medicine formula for treating thyroid adenoma
05/16/2012CN102451402A Antitumor medicinal liquor
05/16/2012CN102451220A Erythrophleum fordii Oliver extract, preparation method and pharmaceutical composition thereof and application
05/16/2012CN102451219A Fermented soya bean active substance and preparation method thereof
05/16/2012CN102451216A Application of anthocyanidin extract in inhibition of PKC-alpha activation and NF-kappaB activation
05/16/2012CN102451215A Extraction technology of gypenoside
05/16/2012CN102451205A Method for extracting anticancer substances from arlia elata
05/16/2012CN102451198A Active traditional Chinese medicine formula for preventing cancers and preparation process thereof
05/16/2012CN102451195A Bifidobacterium antineoplastic agent
05/16/2012CN102451194A Extraction method for scorpion venom
05/16/2012CN102451183A Application of pregnadienolone compound in preparation of antitumor medicament
05/16/2012CN102451179A Enteric solid preparation containing lycopene, resveratrol or melatonin and preparation method of enteric solid preparation
05/16/2012CN102451176A Docetaxel/steroid composite
05/16/2012CN102451175A Resveratrol and bioflavonoid composition as well as preparation and application thereof
05/16/2012CN102451160A Preparation method of long-circulating nanoparticle
05/16/2012CN102451159A Superfine vinpocetine composite particle and preparation method thereof
05/16/2012CN102451157A Docetaxel submicron emulsion with steroid composite as intermediate carrier
05/16/2012CN102451156A Gemcitabine hydrochloride injection preparation and its preparation method
05/16/2012CN102451155A Prescription and preparation method of docetaxel injection
05/16/2012CN102451138A Edible mouthwash capable of preventing cancer
05/16/2012CN102100692B Prenylflavanone compound and use thereof in preparation of anti-tumor medicaments
05/16/2012CN101991581B Application of 3beta, 6beta, 7alpha-trihydroxy-(24R)ergosta-8(14),22-diene in preparation of anti-cancer drugs
05/16/2012CN101781325B Gallium salicylaldehyde amino acid Schiff base quaternary coordination compound, preparation method and application thereof
05/16/2012CN101665479B Technology for synchronously extracting isofraxidin and flavonoids compounds from sarcandra glabra and applications thereof
05/16/2012CN101595130B Compositions and methods for the diagnosis and treatment of tumor
05/16/2012CN101537025B Preparation method for increasing content of total saponin, low polarity saponin and argininyl fructosy glucose in red ginseng
05/16/2012CN101531652B Novel method for extracting anthocyanin in bilberry by double water phases
05/16/2012CN101513400B Ampelopsin and basic amino acid solubilizing system and antitumor activity research
05/16/2012CN101466672B Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide
05/16/2012CN101434635B Water-soluble phenolic triterpenoid with antineoplastic activity and preparation thereof
05/16/2012CN101282936B Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
05/15/2012US8178713 Sulfur-containing phospholipid derivatives
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
05/15/2012US8178543 Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors
05/15/2012US8178510 Preparation of thioarabinofuranosyl compounds and use thereof
05/15/2012US8178131 Pyrrolopyridines as kinase inhibitors
05/15/2012US8178093 Method for treating infectious disease using monoclonal antibodies
05/15/2012CA2694480C Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
05/15/2012CA2681922C Zinc finger protein derivatives and methods therefor
05/15/2012CA2650297C Hydroxymatairesinol in cancer prevention
05/15/2012CA2581843C Thermodynamically stable form of bay 43-9006 tosylate
05/15/2012CA2553328C Pyridinium and quinolinium derivatives
05/15/2012CA2530374C Hsp90 family protein inhibitors
05/15/2012CA2517361C Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
05/15/2012CA2478223C Combinations comprising epothilone derivatives and alkylating agents
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2461227C Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
05/15/2012CA2448933C A retinoic acid metabolizing cytochrome p450
05/15/2012CA2430978C Vla-4 inhibitors
05/15/2012CA2422059C Methods and products related to low molecular weight heparin
05/15/2012CA2402169C Formulation and method for treating neoplasms by inhalation
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/15/2012CA2368385C Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
05/15/2012CA2367291C Amplification of cyp24 and uses thereof
05/10/2012WO2012061750A2 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012WO2012061696A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors
05/10/2012WO2012061662A1 Glycomimetic-peptidomimetic inhibitors of e-selectins and cxcr4 chemokine receptors
05/10/2012WO2012061602A1 Isoindolinone kinase inhibitors
05/10/2012WO2012061601A1 Treatment of pituitary corticotroph tumors using r-roscovitine
05/10/2012WO2012061576A1 Crystalline forms of ( s ) - 2 - amino - 3 - (4 - ( 2 - amino - 6 - ( (r) - 1 - (4 - ch loro-2- (3 -methyl- 1h- pyrazol- 1 -yl) phenyl) - 2, 2, 2 - trifluoroethoxy) pyrimidin- 4 - yl) phenyl) propanoic acid
05/10/2012WO2012061551A1 Administration of nedd8-activating enzyme inhibitor
05/10/2012WO2012061443A2 Compositions of a peptide-based system for cell-specific targeting
05/10/2012WO2012061428A2 Nicotinamides as jak kinase modulators
05/10/2012WO2012061415A1 Oxypyrimidines as syk modulators
05/10/2012WO2012061413A2 Isoflavonoid compositions and methods for the treatment of cancer
05/10/2012WO2012061402A2 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
05/10/2012WO2012061390A2 Therapeutic compositions and methods
1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 2211